Conversely, our results indicate that the treatment with 5-azacytidine, inducing tuberin expression, reduced the senescent features of LAM/TSC cells, which decrease the positivity to SA-β galactosidase. This evidence concerns the gene TSC2 and lymphangioleiomyomatosis.